Ya-Ling Han

Showing 1-7 of 7 articles

Author Yao-Jun Zhang

Coronary interventions

Clinical and multimodality imaging results at 6 months of a bioresorbable sirolimus-eluting scaffold for patients with single de novo coronary artery lesions: the NeoVas first-in-man trial

Zhang Y-J, Wang X-Z, Fu G, Jing Q-M, Wang G, Jin C-Y, Xie L-H, Cai J-Z, Xu B, Han Y-L

November 20, 2016 | 10.4244/EIJV12I10A209

Author Bo Xu

Validation of residual SYNTAX score with second-generation drug-eluting stents: one-year results from the prospective multicentre SEEDS study

Xu B, Yang Y, Han Y-L, Lu S-Z, Li B, Liu Q, Zhu G-Y, Cui J-Y, Li L, Zhao Y-L, Kirtane A

May 20, 2014 | 10.4244/EIJV10I1A12

Author Xi-Yong Yu

Plasma miR-126 as a potential marker predicting major adverse cardiac events in dual antiplatelet-treated patients after percutaneous coronary intervention

Yu X-Y, Chen J, Zheng Z-W, Wu H, Li L-W, Zhang Z-W, Chen Z-H, Lin Q-X, Han Y-L, Zhong S-L

September 27, 2013 | 10.4244/EIJV9I5A90

Author Zhen-Yang Liang

The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation

Liang Z-Y, Han Y-L, Zhang X-L, Li Y, Yan C-H, Kang J

July 26, 2013 | 10.4244/EIJV9I3A53

Author Run-Lin Gao

A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial

Gao R, Xu B, Lansky A, Yang Y, Ma C-S, Han Y-L, Chen S-L, Li H, Zhang R, Fu G, Yuan Z, Jiang H, Huo Y, Li W, Zhang Y-J, Leon M

May 21, 2013 | 10.4244/EIJV9I1A12

Author Xian-Yang Zhu

Long-term efficacy of transcatheter closure of ventricular septal defect in combination with percutaneous coronary intervention in patients with ventricular septal defect complicating acute myocardial infarction: a multicentre study

Zhu X-Y, Qin Y, Han Y-L, Zhang D-Z, Wang P, Liu Y-F, Xu Y-W, Jing Q-M, Xu K, Gersh B, Wang X-Z

March 22, 2013 | 10.4244/EIJV8I11A195

Author Ya-Ling Han

A new generation of biodegradable polymer-coated sirolimus-eluting stents for the treatment of coronary artery disease: final 5-year clinical outcomes from the CREATE study

Han Y-L, Zhang L, Yang L-X, Liu H-L, Qu P, Li W-M, Jiang T, Li S-M, Jing Q-M, Zhang Q-Y, Xu B, Li Y, Gao R

November 20, 2012 | 10.4244/EIJV8I7A124

1

Latest news

Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue

(Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right))

December 6, 2019

The challenge of innovation for the (interventional?) cardiology world

December 6, 2019

This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more

December 3, 2019

New update! Discover 17 new trials

(The Trials book is supported by Biotronik)

October 29, 2019

Guidance Papers

Guidelines, consensus & position papers

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

Last week's JAA's: DYNAMIC Trial, S3U registry and much more

November 26, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke